Germany
Japan
United Kingdom
China
USD 880.00
3 Weeks
Lenti ORF particles, NOX4 (mGFP-tagged) - Human NADPH oxidase 4 (NOX4), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lentiviral Particles
USD 820.00
3 Weeks
Lenti ORF particles, F2R (mGFP-tagged) - Human coagulation factor II (thrombin) receptor (F2R), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
3 Weeks
Lenti ORF particles, MRGPRX2 (mGFP-tagged) - Human MAS-related GPR, member X2 (MRGPRX2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,000.00
3 Weeks
Lenti ORF particles, ERBB3 (Myc-DDK tagged) - Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (ERBB3), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, MS4A6A (mGFP-tagged) - Human membrane-spanning 4-domains, subfamily A, member 6A (MS4A6A), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
3 Weeks
Lenti ORF particles, PRKCA (mGFP-tagged)-Human protein kinase C, alpha (PRKCA), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, HAVCR1 (Myc-DDK tagged) - Human hepatitis A virus cellular receptor 1 (HAVCR1), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TRPV1 (Myc-DDK tagged) - Human transient receptor potential cation channel, subfamily V, member 1 (TRPV1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TRPV1 (mGFP-tagged) - Human transient receptor potential cation channel, subfamily V, member 1 (TRPV1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, FGFR1 (mGFP-tagged) - Human fibroblast growth factor receptor 1 (FGFR1), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SMURF1 (mGFP-tagged) - Human SMAD specific E3 ubiquitin protein ligase 1 (SMURF1), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 830.00
5 Weeks
Lenti ORF particles, CHKA (Myc-DDK tagged) - Human choline kinase alpha (CHKA), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, TNFSF4 (Myc-DDK tagged) - Human tumor necrosis factor (ligand) superfamily, member 4 (TNFSF4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, KDM5C (Myc-DDK-tagged)-Human lysine (K)-specific demethylase 5C (KDM5C), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, KDM5C (mGFP-tagged)-Human lysine (K)-specific demethylase 5C (KDM5C), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Active filters
Category
-
cDNA Clones
- Lentiviral Particles
Species
- Human
Mammalian Cell Selection
- Puromycin
Families
- Druggable Genome
Brands
- LentiORF
Filter by
Target Symbol
- PDE9A (40)
- NRG1 (36)
- CREM (34)
- DTNA (34)
- BDNF (32)
- VEGFA (32)
- NR1I3 (30)
- CD1E (26)
- CTNND1 (26)
- DAG1 (26)
- OPRM1 (26)
- ASPH (24)
- ATXN3 (24)
- CD46 (24)
- FGFR1 (22)
- SERPINA1 (22)
- MADD (20)
- PTPN20 (20)
- TCF7L2 (20)
- ABL2 (18)
- ADGRG2 (18)
- APTX (18)
- BCAR1 (18)
- CACNB2 (18)
- CSF2RA (18)
- FGFR2 (18)
- HFE (18)
- NEDD4L (18)
- NF2 (18)
- PDE4D (18)
- PML (18)
- PTGER3 (18)
- PTPN20A (18)
- ADGRG1 (16)
- CAMK2B (16)
- CD59 (16)
- CHRM2 (16)
- ENSA (16)
- GSN (16)
- IP6K2 (16)
- MID1 (16)
- MITF (16)
- MYB (16)
- OGG1 (16)
- PAX3 (16)
- PCSK6 (16)
- RAD17 (16)
- TGIF1 (16)
- TNIK (16)
- TRPM3 (16)
- ANAPC11 (14)
- APP (14)
- ATP2A3 (14)
- CAMKK2 (14)
- CAPN3 (14)
- CHAT (14)
- CPT1B (14)
- DBI (14)
- GABRA1 (14)
- HMGA1 (14)
- IMPDH1 (14)
- KCNIP2 (14)
- MAP7 (14)
- MEN1 (14)
- MUC1 (14)
- NEK6 (14)
- NR3C1 (14)
- PPP2R2B (14)
- PREPL (14)
- PROM1 (14)
- PTCH1 (14)
- RABL2B (14)
- RASGRP4 (14)
- SEPT9 (14)
- SIGLEC10 (14)
- SORBS1 (14)
- TP53 (14)
- TPM1 (14)
- SMARCA4 (13)
- ABCG1 (12)
- ADAM15 (12)
- AFF2 (12)
- AGL (12)
- AMZ2 (12)
- ASNS (12)
- AURKA (12)
- BTNL8 (12)
- CAMK2D (12)
- CARD8 (12)
- CASP8 (12)
- CDK11B (12)
- CLEC7A (12)
- CNBP (12)
- CNOT4 (12)
- DCN (12)
- DCTN1 (12)
- EPB41 (12)
- FGF1 (12)
- GIT2 (12)
- GUCY1A1 (12)
Lentivirus
Mutants
Pathways
- Metabolic pathways (1781)
- Pathways in cancer (1142)
- MAPK signaling pathway (888)
- Neuroactive ligand-receptor interaction (878)
- Cytokine-cytokine receptor interaction (852)
- Regulation of actin cytoskeleton (615)
- Focal adhesion (577)
- Chemokine signaling pathway (564)
- Calcium signaling pathway (561)
- Wnt signaling pathway (478)
- Neurotrophin signaling pathway (475)
- Jak-STAT signaling pathway (459)
- Progesterone-mediated oocyte maturation (422)
- Insulin signaling pathway (392)
- T cell receptor signaling pathway (390)
- Purine metabolism (389)
- Endocytosis (379)
- Cell cycle (374)
- ErbB signaling pathway (372)
- Natural killer cell mediated cytotoxicity (372)
- Axon guidance (356)
- Apoptosis (347)
- Prostate cancer (341)
- Oocyte meiosis (340)
- Toll-like receptor signaling pathway (338)
- Hematopoietic cell lineage (330)
- Adherens junction (325)
- Ubiquitin mediated proteolysis (320)
- Colorectal cancer (317)
- Alzheimer's disease (314)
- Leukocyte transendothelial migration (314)
- GnRH signaling pathway (312)
- Pancreatic cancer (302)
- Melanogenesis (300)
- Vascular smooth muscle contraction (288)
- Cell adhesion molecules (CAMs) (285)
- Gap junction (271)
- VEGF signaling pathway (271)
- Huntington's disease (270)
- Dilated cardiomyopathy (268)
- Olfactory transduction (268)
- B cell receptor signaling pathway (262)
- Chronic myeloid leukemia (262)
- Renal cell carcinoma (262)
- Melanoma (260)
- Tight junction (257)
- Small cell lung cancer (256)
- TGF-beta signaling pathway (256)
- p53 signaling pathway (256)
- Fc gamma R-mediated phagocytosis (250)
- Hypertrophic cardiomyopathy (HCM) (250)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (244)
- Fc epsilon RI signaling pathway (236)
- Glioma (236)
- Lysosome (236)
- NOD-like receptor signaling pathway (233)
- Acute myeloid leukemia (232)
- Adipocytokine signaling pathway (228)
- Complement and coagulation cascades (226)
- Long-term potentiation (222)
- Phosphatidylinositol signaling system (215)
- Long-term depression (214)
- Endometrial cancer (210)
- Amyotrophic lateral sclerosis (ALS) (201)
- RIG-I-like receptor signaling pathway (196)
- PPAR signaling pathway (194)
- Non-small cell lung cancer (190)
- ECM-receptor interaction (187)
- Bladder cancer (184)
- Basal cell carcinoma (162)
- Glycolysis / Gluconeogenesis (161)
- Epithelial cell signaling in Helicobacter pylori infection (157)
- Inositol phosphate metabolism (153)
- Viral myocarditis (152)
- mTOR signaling pathway (146)
- Type II diabetes mellitus (144)
- Drug metabolism - cytochrome P450 (138)
- Thyroid cancer (136)
- Cardiac muscle contraction (132)
- Hedgehog signaling pathway (132)
- Pathogenic Escherichia coli infection (132)
- Metabolism of xenobiotics by cytochrome P450 (130)
- Glycerophospholipid metabolism (128)
- Pyrimidine metabolism (128)
- ABC transporters (123)
- Valine (123)
- Cytosolic DNA-sensing pathway (122)
- Antigen processing and presentation (120)
- Arachidonic acid metabolism (120)
- Parkinson's disease (118)
- Retinol metabolism (118)
- Arginine and proline metabolism (113)
- Primary immunodeficiency (112)
- Glycerolipid metabolism (107)
- Drug metabolism - other enzymes (106)
- Tyrosine metabolism (106)
- Base excision repair (105)
- leucine and isoleucine degradation (97)
- Glutathione metabolism (92)
- Fatty acid metabolism (91)
- Autoimmune thyroid disease (90)
- Sphingolipid metabolism (90)
- Systemic lupus erythematosus (89)
- Lysine degradation (88)
- Taste transduction (88)
- Fructose and mannose metabolism (86)
- Cysteine and methionine metabolism (84)
- Prion diseases (83)
- Nucleotide excision repair (82)
- SNARE interactions in vesicular transport (80)
- Starch and sucrose metabolism (79)
- Vibrio cholerae infection (79)
- Amino sugar and nucleotide sugar metabolism (78)
- Galactose metabolism (78)
- Pyruvate metabolism (75)
- Tryptophan metabolism (75)
- Butanoate metabolism (71)
- Type I diabetes mellitus (70)
- Alanine (68)
- Notch signaling pathway (68)
- aspartate and glutamate metabolism (68)
- Proteasome (66)
- Homologous recombination (64)
- Linoleic acid metabolism (64)
- Pentose phosphate pathway (62)
- Histidine metabolism (61)
- Aminoacyl-tRNA biosynthesis (60)
- Androgen and estrogen metabolism (60)
- Ether lipid metabolism (60)
- Nitrogen metabolism (60)
- Oxidative phosphorylation (60)
- Maturity onset diabetes of the young (58)
- Renin-angiotensin system (58)
- Propanoate metabolism (57)
- Citrate cycle (TCA cycle) (54)
- Regulation of autophagy (54)
- Allograft rejection (52)
- Mismatch repair (52)
- Glycosaminoglycan degradation (46)
- Porphyrin and chlorophyll metabolism (46)
- Riboflavin metabolism (45)
- Phenylalanine metabolism (44)
- Spliceosome (44)
- Dorso-ventral axis formation (42)
- Ribosome (42)
- Selenoamino acid metabolism (42)
- Pantothenate and CoA biosynthesis (41)
- Non-homologous end-joining (40)
- leucine and isoleucine biosynthesis (40)
- beta-Alanine metabolism (39)
- Graft-versus-host disease (38)
- DNA replication (36)
- Glycine (36)
- N-Glycan biosynthesis (36)
- Other glycan degradation (36)
- Steroid biosynthesis (36)
- serine and threonine metabolism (36)
- C21-Steroid hormone metabolism (34)
- Circadian rhythm - mammal (32)
- Primary bile acid biosynthesis (32)
- alpha-Linolenic acid metabolism (32)
- Asthma (30)
- Folate biosynthesis (28)
- Terpenoid backbone biosynthesis (28)
- Synthesis and degradation of ketone bodies (24)
- Basal transcription factors (22)
- RNA degradation (22)
- Pentose and glucuronate interconversions (20)
- Nicotinate and nicotinamide metabolism (19)
- Glyoxylate and dicarboxylate metabolism (18)
- Ascorbate and aldarate metabolism (17)
- Biosynthesis of unsaturated fatty acids (16)
- Glycosphingolipid biosynthesis - globo series (16)
- One carbon pool by folate (16)
- Thiamine metabolism (16)
- Limonene and pinene degradation (15)
- Glycosphingolipid biosynthesis - lacto and neolacto series (14)
- Ubiquinone and other terpenoid-quinone biosynthesis (14)
- Caffeine metabolism (12)
- Glycosphingolipid biosynthesis - ganglio series (12)
- Sulfur metabolism (12)
- Fatty acid elongation in mitochondria (10)
- Heparan sulfate biosynthesis (10)
- Protein export (10)
- Taurine and hypotaurine metabolism (10)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (8)
- Methane metabolism (8)
- Phenylalanine (8)
- tyrosine and tryptophan biosynthesis (8)
- RNA polymerase (6)
- Chondroitin sulfate biosynthesis (4)
- Fatty acid biosynthesis (4)
- O-Glycan biosynthesis (4)
- Vitamin B6 metabolism (4)
- Biotin metabolism (2)
- D-Arginine and D-ornithine metabolism (2)
- D-Glutamine and D-glutamate metabolism (2)
- Keratan sulfate biosynthesis (2)
- Lysine biosynthesis (2)